Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 103

1.

The Ottawa score performs poorly in cancer patients with incidental pulmonary embolism.

Mulder FI, Kraaijpoel N, Di Nisio M, Meyer G, Mahé I, Muñoz A, Bertoletti L, Biosca M, Maraveyas A, Büller HR, van Es N.

Thromb Res. 2019 Sep;181:59-63. doi: 10.1016/j.thromres.2019.07.005. Epub 2019 Jul 11.

PMID:
31352267
2.

Extended treatment with edoxaban in cancer patients with venous thromboembolism: A post-hoc analysis of the Hokusai-VTE Cancer study.

Di Nisio M, van Es N, Carrier M, Wang TF, Garcia D, Segers A, Weitz J, Buller H, Raskob G.

J Thromb Haemost. 2019 Jul 4. doi: 10.1111/jth.14561. [Epub ahead of print]

PMID:
31271705
3.

Treatment and Long-Term Clinical Outcomes of Incidental Pulmonary Embolism in Patients With Cancer: An International Prospective Cohort Study.

Kraaijpoel N, Bleker SM, Meyer G, Mahé I, Muñoz A, Bertoletti L, Bartels-Rutten A, Beyer-Westendorf J, Porreca E, Boulon C, van Es N, Iosub DI, Couturaud F, Biosca M, Lerede T, Lacroix P, Maraveyas A, Aggarwal A, Girard P, Büller HR, Di Nisio M; UPE investigators.

J Clin Oncol. 2019 Jul 10;37(20):1713-1720. doi: 10.1200/JCO.18.01977. Epub 2019 May 22.

PMID:
31116676
4.

Proximal and isolated distal deep vein thrombosis and Wells score accuracy in hospitalized patients.

Di Nisio M, Valeriani E, Porreca E.

Intern Emerg Med. 2019 Sep;14(6):901-902. doi: 10.1007/s11739-019-02098-0. Epub 2019 May 9. No abstract available.

PMID:
31073826
5.

Treatment of venous thromboembolism with tinzaparin in oncological patients.

Ageno W, Barni S, Di Nisio M, Falanga A, Imberti D, Labianca RF, Mantovani L.

Minerva Med. 2019 Jun;110(3):251-258. doi: 10.23736/S0026-4806.19.06026-9. Review.

6.

Long-term performance of risk scores for venous thromboembolism in ambulatory cancer patients.

Di Nisio M, van Es N, Rotunno L, Anzoletti N, Falcone L, De Tursi M, Natoli C, Tinari N, Cavallo I, Valeriani E, Candeloro M, Guglielmi MD, Rutjes AWS, Porreca E.

J Thromb Thrombolysis. 2019 Jul;48(1):125-133. doi: 10.1007/s11239-019-01845-6.

PMID:
30919253
7.

Computerised cognitive training for preventing dementia in people with mild cognitive impairment.

Gates NJ, Vernooij RW, Di Nisio M, Karim S, March E, Martínez G, Rutjes AW.

Cochrane Database Syst Rev. 2019 Mar 13;3:CD012279. doi: 10.1002/14651858.CD012279.pub2.

PMID:
30864747
8.

Computerised cognitive training for maintaining cognitive function in cognitively healthy people in midlife.

Gates NJ, Rutjes AW, Di Nisio M, Karim S, Chong LY, March E, Martínez G, Vernooij RW.

Cochrane Database Syst Rev. 2019 Mar 13;3:CD012278. doi: 10.1002/14651858.CD012278.pub2.

PMID:
30864746
9.

Computerised cognitive training for maintaining cognitive function in cognitively healthy people in late life.

Gates NJ, Rutjes AW, Di Nisio M, Karim S, Chong LY, March E, Martínez G, Vernooij RW.

Cochrane Database Syst Rev. 2019 Mar 13;3:CD012277. doi: 10.1002/14651858.CD012277.pub2.

PMID:
30864187
10.

The Khorana score for prediction of venous thromboembolism in cancer patients: a systematic review and meta-analysis.

Mulder FI, Candeloro M, Kamphuisen PW, Di Nisio M, Bossuyt PM, Guman N, Smit K, Büller HR, van Es N; CAT-prediction collaborators.

Haematologica. 2019 Jun;104(6):1277-1287. doi: 10.3324/haematol.2018.209114. Epub 2019 Jan 3.

11.

Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life.

Rutjes AW, Denton DA, Di Nisio M, Chong LY, Abraham RP, Al-Assaf AS, Anderson JL, Malik MA, Vernooij RW, Martínez G, Tabet N, McCleery J.

Cochrane Database Syst Rev. 2018 Dec 17;12:CD011906. doi: 10.1002/14651858.CD011906.pub2.

PMID:
30556597
12.

Vitamin and mineral supplementation for preventing dementia or delaying cognitive decline in people with mild cognitive impairment.

McCleery J, Abraham RP, Denton DA, Rutjes AW, Chong LY, Al-Assaf AS, Griffith DJ, Rafeeq S, Yaman H, Malik MA, Di Nisio M, Martínez G, Vernooij RW, Tabet N.

Cochrane Database Syst Rev. 2018 Nov 1;11:CD011905. doi: 10.1002/14651858.CD011905.pub2.

PMID:
30383288
13.

Treatment of Lower Extremity Superficial Thrombophlebitis.

Di Nisio M, Wichers I, Middeldorp S.

JAMA. 2018 Dec 11;320(22):2367-2368. doi: 10.1001/jama.2018.16623.

PMID:
30383173
14.

[Treatment of cancer-associated venous thromboembolism].

Di Nisio M.

G Ital Cardiol (Rome). 2018 Sep;19(9):7-12. doi: 10.1714/2989.29922. Italian.

PMID:
30284557
15.

Lemierre Syndrome: Clinical Update and Protocol for a Systematic Review and Individual Patient Data Meta-analysis.

Sacco C, Zane F, Granziera S, Holm K, Creemers-Schild D, Hotz MA, Turpini E, Valentini A, Righini C, Karkos PD, Verhamme P, Di Nisio M, Konstantinides S, Pecci A, Barco S; Lemierre Study Group .

Hamostaseologie. 2019 Feb;39(1):76-86. doi: 10.1055/s-0038-1654720. Epub 2018 Aug 2.

PMID:
30071559
16.

Clinical Impact of Bleeding in Cancer-Associated Venous Thromboembolism: Results from the Hokusai VTE Cancer Study.

Kraaijpoel N, Di Nisio M, Mulder FI, van Es N, Beyer-Westendorf J, Carrier M, Garcia D, Grosso M, Kakkar AK, Mercuri MF, Middeldorp S, Hernandez CR, Santamaria A, Schwocho L, Segers A, Verhamme P, Wang TF, Weitz JI, Zhang G, Zwicker JI, Büller HR, Raskob GE.

Thromb Haemost. 2018 Aug;118(8):1439-1449. doi: 10.1055/s-0038-1667001. Epub 2018 Jul 30.

PMID:
30060256
17.

Bleeding and venous thromboembolic events in patients with active cancer hospitalized for an acute medical illness.

Di Nisio M, Candeloro M, Rutjes AWS, Galli V, Tritto M, Porreca E.

Thromb Res. 2018 Sep;169:44-49. doi: 10.1016/j.thromres.2018.07.010. Epub 2018 Jul 6.

PMID:
30015227
18.

Antithrombotic therapy for venous thromboembolism in patients with cancer: expert guidance.

Imberti D, Cimminiello C, Di Nisio M, Marietta M, Polo Friz H, Ageno W.

Expert Opin Pharmacother. 2018 Aug;19(11):1177-1185. doi: 10.1080/14656566.2018.1496238. Epub 2018 Jul 16. Review.

PMID:
29963962
19.

A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts.

Pabinger I, van Es N, Heinze G, Posch F, Riedl J, Reitter EM, Di Nisio M, Cesarman-Maus G, Kraaijpoel N, Zielinski CC, Büller HR, Ay C.

Lancet Haematol. 2018 Jul;5(7):e289-e298. doi: 10.1016/S2352-3026(18)30063-2. Epub 2018 Jun 7. Erratum in: Lancet Haematol. 2018 Jun 15;:.

20.

Risk Scores for Occult Cancer in Patients with Venous Thromboembolism: A Post Hoc Analysis of the Hokusai-VTE Study.

Kraaijpoel N, van Es N, Raskob GE, Büller HR, Carrier M, Zhang G, Lin M, Grosso MA, Di Nisio M.

Thromb Haemost. 2018 Jul;118(7):1270-1278. doi: 10.1055/s-0038-1649523. Epub 2018 Jun 4.

PMID:
29864787

Supplemental Content

Loading ...
Support Center